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Abstract 
Aggressive Angiomyxoma (AA) is a soft tissue tumour that 
principally affects women of the reproductive age, 
primarily involving the pelvis and the perineum. Despite 
being slow growing, it is classified as aggressive due to its 
locally infiltrative nature and high recurrence. It is rare, 
often asymptomatic and is misdiagnosed. However, it has 
characteristic features on radiographic imaging. 
Complete surgical resection is the ideal approach to treat 
AA. We report a case of an aggressive angiomyxoma in a 
17 year old female, located in the ischiorectal fossa and 
diagnosed incidentally on a magnetic resonance imaging 
(MRI). The lesion was excised without complication. 
Keywords: Aggressive angiomyxoma, Mesenchymal 
neoplasm, Perineal tumour. 
DOI: https://doi.org/10.5455/JPMA.30242 
Introduction 
Aggressive angiomyxoma is a slow growing 
mesenchymal neoplasm.1 It arises primarily in the deep 
soft tissues of the pelvis, perineum of the reproductive 
age women and in the inguinoscrotal region in the men. 
The tumour has a locally infiltrative nature. It has a high 
rate of local recurrence (70%) but lacks metastatic 
potential.2,3 Clinically, patients are often asymptomatic 
and may be misdiagnosed. The tumour is usually large 
(>10cm) and is discovered during pelvic examination or 
on a radiographic imaging.1,4,5 It has a lobulated 
appearance with a soft rubbery consistency and may 
infiltrate into surrounding tissues.3 On magnetic 
resonance imaging (MRI), it has a characteristic internal 
low intensity swirled appearance on both T1 and T2 
weighted images.4  Histologic examination reveals a 
sparsely cellular tumour consisting of spindle and stellate-
shaped cells in a myxoid background studded with blood 
vessels.2 Treatment modality includes a wide local 
surgical excision with a long term follow-up.3,6 We report 
a case of a 17-year-old female being evaluated for a year 
long history of lower back pain who was incidentally 
found to have a mass in the ischiorectal fossa on a MRI. It 
is unique, because it is a rare and slowly progressing 
disease with vague symptoms, difficult diagnosis and no 
definite treatment guidelines. In our case, a successful 
complete surgical resection with clear margins was 
performed which is generally the preferred treatment. 
This could add to the literature of successful cases and can 
potentially help define treatment in the future. Informed 
consent was taken from the patient for writing the report. 
Case Presentation 
A 17-year-old female with an unremarkable medical and 
surgical history presented to the clinic with lower back 
pain. It was associated with a burning sensation localized 
to the lower back along with numbness radiating to the 
legs. Clinical examination was unremarkable. She was 
managed conservatively with analgesics and muscle 
relaxants but had persistent symptoms, she presented 
first time at Aga Khan University Hospital, Karachi on 8th 
August 2017. 
A pelvic MRI was obtained, which did not identify any 
spinal pathology. However, it showed a 1.9 x 2.1 cm well-
defined rounded lesion in the right ischiorectal fossa 
closely abutting right obturator internus with an intact fat 
planes laterally and anteromedially, extending to the 
levatorani muscle. The lesion was hypointense on T1 and 
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Figure-1: View of the structures within the perianal region before excision of the 
tumour.
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hyperintense on T2-weighted images, with subtle post-
contrast enhancement. She was referred for surgical 
evaluation 5 months after her initial MRI and was advised 
a repeat MRI. It revealed an increase in the size (4 x 3 cm) 
of the lesion. Differential diagnosis after a repeat MRI 
included a lipoma and a liposarcoma. A computed 
tomography (CT) scan guided core biopsy was suggestive 
of an aggressive angiomyxoma. A decision for surgical 
excision was made. 
Bowel was prepared with rectal enemas. After the 
administration of general anaesthesia, patient was placed 
in a prone-jackknife position. A 6cm crescent incision was 
placed over the right ischiorectal fossa. Dissection was 
continued proximally into the space using electrocautery 
as shown in Figure-1. With help of a manual palpation, the 
lesion was identified and sharply dissected and care was 
taken not to breach the capsule. The lesion was well 
circumscribed without any signs of surrounding 
infiltration or extension into the rectum medially or in the 
levatorani superiorly. On excision, the lesion was noted to 
be soft with a smooth surface, measuring 7 x 4.5 x 2 cm 
(Figure-2). 
On histopathology, the cut surface was grey-white. 
Microscopic examination revealed a neoplastic lesion 
comprising of haphazard arrangement of spindle shaped 
cells in a myxoid background. Individual cells had 
elongated vesicular nuclei, inconspicuous nucleoli, scant 
eosinophilic cytoplasm and interspersed thin strands of 
collagen. Vessels showed adventitial thickening with 
perivascular lymphocytic cuffing with presence of smooth 
muscle cells. Occasional mitotic figures were seen but 
necrosis was absent. The tumour's histological features 
were consistent with an aggressive angiomyxoma. 
Immunohistochemistry showed positive desmin, CD 34 
and ER signals while S-100 and an alpha smooth muscle 
actin (α - SMA) were negative. 
No post-surgery complications were seen; wound site was 
managed with dressing and stitches were removed within 
2 weeks. Patient complained of constipation 
postoperatively for 2 weeks which responded to 
medications and dietary manipulation. Follow up scan 
after 6 and 12 months revealed no recurrence of the 
disease. 
Discussion 
Aggressive Angiomyxoma (AA), a slow growing and 
benign mesenchymal tumour occurs in women in their 
40s and 50s.2,4 It usually occurs in the female pelvis and 
the perineum especially, the vulva. We the report a case of 
a 17-year-old female in the ischiorectal fossa. In men, AA 
is rarely reported, usually involving the inguinoscrotal 
region.  Male to female ratio is 1:6.6.3 In a study reported 
from Pakistan, it was seen to comprise of 10% of the 
benign tumours of the vulva.7 
AA usually causes displacement of adjacent organs 
typically without invasion. However, due to its locally 
infiltrative and aggressive nature it can cause invasion 
during longstanding growth.6 These tumours have a high 
rate of local recurrence varying from 36-70%, usually 
within the first two years. However, it is treated by re-
excision with a 1cm margin.1,6 
Patients are often asymptomatic or present with a 
painless mass. However, our patient had a year long 
history of nonspecific back pain which had resolved by 
the time she came for the surgery. Due to their location, 
AAs are usually large and measure more than 10 cm at the 
time of the diagnosis. Frequently the large, deep seated 
pelvic component of the aggressive angiomyxomas in 
relation to the pelvic diaphragm is not appreciated on 
clinical examination and can often be missed.8  
Clinically, differential diagnosis of AA includes myxoma, 
myxoid liposarcoma, pelvic fibromatosis, levator hernia, 
bartholin cyst, labial cyst, gartner duct cyst or lipoma.1,5 
The main histologic differential consideration would be 
an angiomyofibroblastoma. 
Imaging modalities that assist with diagnosis include CT 
scan, MRI and pelvic digital subtraction angiography 
(DSA).9 Sonographic imaging shows a hypoechoic or a 
cystic mass.4 Angiography typically shows a hyper 
vascular mass.9 On CT scan, the tumour has a distinct 
border with minimal hypodensity compared to muscle. 
On MRI, both T1-weighted and T2-weighted images, mass 
Figure-2: Gross examination of the excised tumour.
has areas of "swirled" linear low-intensity signal 
suggesting a fibrovascular stroma. On T1-weighted 
images, the tumour is isointense compared to a muscle. 
T2-weighted images show a hyperintense tumour due to 
high water content and loose myxoid matrix. In our 
patient, we report similar findings on a MRI.4 
On gross assessment, tumours are usually not 
encapsulated and have sharp margination in some areas 
while blending gradually with surrounding soft tissue in 
others. Areas of congested blood vessels, haemorrhage or 
fibrosis may be present.9 Our patient's tumour had a 
similar appearance (Figure-2), on inspection it was a 
pink/gray mass with a rubbery texture and a gelatinous 
glistening cut surface. Microscopic findings in our patient 
are consistent with those reported in the literature. 
Resection margins are usually positive due to the 
tumour's tendency to infiltrate local tissues.  Almost all AA 
on immunohistochemistry show positive vimentin and 
desmin signals with a negative S-100 signals. The positive 
rates of CD34, smooth muscle actin (SMA), a-SMA, 
oestrogen receptor (ER) or progesterone receptor (PR) 
have been reported many times in the literature4. We 
report positive desmin, CD 34, ER signals along with a 
negative S-100 and a-SMA signals. Recent molecular 
assessments indicate that certain genetic alterations 
appear to have a role in the pathogenesis of this tumour 
and may be useful markers for microscopic residual 
disease.  
Complete surgical resection of the lesion must be 
considered, as done in our case. Partial resection is 
considered when a high surgical morbidity or a mutilating 
surgery is anticipated. This can be bolstered with adjunct 
therapies, including arterial embolization, hormonal 
treatment or radiotherapy.10 
There are no definite guidelines on the postoperative 
management of AA.  Since the recurrence rate is as high 
as 72% and  undiagnosed occurrences are associated with 
morbidity, various authors have recommend periodic 
assessment comprising of physical examination and a MRI 
after the surgical resection. Follow-up for up to 15 years 
has been described.10 At 1 year our patient showed no 
evidence of recurrent disease. A definite prognosis of this 
would require a long term follow up, which is a limitation 
in this report. 
Conclusion 
Angiomyxoma is a rare tumour that is often missed due to 
an unremarkable clinical examination. It is common in 
women of mid-30s, however, it can also present in 
teenagers, as in our case. No definite guidelines exist 
regarding its management but complete surgical 
resection is the key treatment. However, regular long 
follow-ups are needed to assess the recurrence. 
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